# FDA Warning Letter: Hemarus LLC
> 2024-10-15 · Center for Biologics Evaluation and Research (CBER) · `0b112675edc09a0a`
## Letter
- **Company:** Hemarus LLC
- **Posted Date:** 2024-10-15
- **Letter Issue Date:** 2024-10-08
- **Issuing Office:** Center for Biologics Evaluation and Research (CBER)
## Subject
CGMP/Blood & Blood Components/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*